|Articles|November 19, 2015

Michael J. Mauro Discusses the Diagnosis of CML

Michael J. Mauro, leader, Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, discusses the diagnosis of chronic myeloid leukemia (CML).

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!

Related Content

What is the Goal of Multiple Myeloma Treatment?

BySaad Usmani, MD

February 3rd 2026

Doctor Outlines Cervical Cancer Care, Side Effects, HPV Prevention

ByDr. Merieme Klobocista

February 2nd 2026

Dr. Suneel Kamath addresses patient concerns on the topic of clinical trial participation in the gastrointestinal cancer treatment space.

Why Clinical Trials May Offer More for Patients With GI Cancers

ByDr. Suneel Kamath

February 2nd 2026

Breaking Down Surgical Advancements for Those With Breast Cancer

ByDr. Kathie-Ann Joseph

February 2nd 2026

What MRD Testing Can Mean for Patients With Breast Cancer and Survivors

ByDr. Pablo Prichard

February 1st 2026

Michael J. Mauro Discusses the Diagnosis of CML

Newsletter

Related Content

What is the Goal of Multiple Myeloma Treatment?

Doctor Outlines Cervical Cancer Care, Side Effects, HPV Prevention

Why Clinical Trials May Offer More for Patients With GI Cancers

Breaking Down Surgical Advancements for Those With Breast Cancer

What MRD Testing Can Mean for Patients With Breast Cancer and Survivors

Trending on CURE

Doctor Outlines Cervical Cancer Care, Side Effects, HPV Prevention

FDA to Review New Drug Combo for Previously Treated Metastatic Colorectal Cancer

Erleada Shows Survival Advantage in Real-World Study of Metastatic Prostate Cancer

Expert Insights: FDA Approval of Lymphir for Cutaneous T-Cell Lymphoma

Breaking Down Surgical Advancements for Those With Breast Cancer